T he acute respiratory distress syndrome (ARDS) is associated with an overall mortality of 35-50% (1, 2) . Recently, a multiple-center trial conducted by the ARDS Network reported a 22% relative reduction in mortality by instituting a strategy of low tidal volume ventilation in patients with ARDS and acute lung injury (ALI) (3) . Despite this impressive risk reduction, concerns exist about possible patient discomfort during ventilation with low tidal volumes (4 -6) . The ARDS Network protocol involves lowering the delivered tidal volume to between 4 and 6 mL per kilogram of predicted body weight. This results in smaller breaths that can cause dyspnea, breath stacking, and patient-ventilator asynchrony (7) (8) (9) . Low tidal volumes can also result in reduced minute ventilation and subsequent hypercapnea, which is known to cause dyspnea independent of breathing pattern (10) . For these reasons, patients receiving low tidal ventilation are often perceived as needing high doses of sedatives and opioid analgesics (4, 5, 11, 12) .
A growing body of literature, however, suggests that high sedative and opioid doses can result in adverse outcomes in mechanically ventilated patients (13) . Studies have shown high doses of continuous sedation to be associated with prolonged mechanical ventilation (14, 15) , ventilator-associated pneumonia (16) , delirium (17, 18) , and decreased long-term quality of life (19) .
To date, the effect of mode of mechanical ventilation on sedative requirements in ALI has been examined only in small studies (20, 21) . The ARDS Network trial reported that there were no significant differences in the percentage of days in which patients received sedation and neuromuscular blocking agents but did not analyze individual drug doses or proportions of patients receiving drugs on a given day (3) . Given these concerns, it is important to better understand the interplay between low tidal volume ventilation and the use of sedatives and analgesics. The purpose of this study was to compare the doses of sedatives and opioid analgesics administered to patients receiving low vs. traditional tidal volumes within the ARDS network trial. Portions of this work have been previously published in abstract form (22) .
METHODS
Study Population. The study was conducted at Harborview Medical Center, a 368-bed, county teaching hospital and level I trauma center affiliated with the University of Washington in Seattle, WA. Patients were identified from local participants in the National Heart, Lung and Blood Institute ARDS Network tidal volume trial (3). This trial was conducted at ten university centers between March 1996 and March 1999 and randomized patients with ALI to a lower tidal volume ventilator strategy (6 mL/kg of predicted body weight) or a higher tidal volume ventilator strategy (12 mL/kg of predicted body weight). ALI was defined as a ratio of PaO 2 to FIO 2 of Յ300, bilateral pulmonary infiltrates on chest radiograph, and no clinical evidence of left atrial hypertension. All patients participating Objective: Low tidal volume ventilation is associated with reduced mortality in patients with acute lung injury, yet concerns exist about patient comfort and the levels of sedation and analgesia required during its use. We compared the doses and duration of sedatives and opioid analgesics in patients receiving low vs. traditional tidal volumes at our institution.
Design: Secondary analysis of a randomized clinical trial. Setting: University-affiliated county hospital in Seattle, WA. Patients: Sixty-one patients with acute lung injury enrolled in the National Heart, Lung and Blood Institute's ARDS Network tidal volume trial.
Interventions: None. Measurements and Main Results: Thirty-three patients were randomized to the lower tidal volume arm (6 mL/kg of predicted body weight) and 28 patients were randomized to the higher tidal volume arm (12 mL/kg of predicted body weight). There were no significant differences in the percentage of study days patients received sedatives, opioids, or neuromuscular blockade. When specific study days were examined, there were no significant differences in the proportion of patients receiving benzodiazepines, propofol, haloperidol, and opioids on days 1, 2, 3, and 7 of mechanical ventilation, nor were there differences in the doses of benzodiazepines and opioids on those days. During the study period, ventilation management and weaning were controlled by fixed protocol in both groups. Sedation practice was determined independently by the intensive care unit (ICU) team, who by study design were not blinded to treatment group. Doses of sedative and opioid analgesic agents, as well as whether to administer neuromuscular blocking drugs, were determined by the treating physicians and nurses with the assistance of a clinical pharmacist who participated in daily rounds. Assessment of level of anxiety, pain, oxygenation, and ventilator synchrony was made at regular intervals by the nurse; sedation and opioid doses were adjusted on this basis. Formal daily interruption of sedation, sedation assessment scores (such as the Ramsey score), and protocolized sedation orders were not employed in the ICUs at the time of the study.
Conclusions
Study Design and Data Collection. The study design was a secondary analysis of a randomized clinical trial. Following patient identification, the medical records were reviewed to obtain daily doses of all sedatives, opioids, neuromuscular blockers, and haloperidol administered during the study period. Medication doses were recorded beginning on the day of randomization and ending upon death, extubation, or day 28 of mechanical ventilation. Analyses therefore involve only patients alive and receiving mechanical ventilation on a given day. Sedative agents included benzodiazepines and propofol. To simplify comparisons, doses of benzodiazepines were converted to lorazepam equivalents using the following formula: 5 mg of diazepam ϭ 2.5 mg of midazolam ϭ 1 mg of lorazepam (23) . Doses of opioids were similarly converted to morphine equivalents using the following formula: 10 mg of morphine ϭ 75 mg of meperidine ϭ 0.1 mg of fentanyl (24) . Nonopioid analgesics such as nonsteroidal anti-inflammatory drugs and acetaminophen were not considered in the analysis. Any calendar day in which a patient received a sedative or opioid was considered a sedation or analgesic day. Any calendar day in which a patient received more than a single dose or a continuous infusion of a neuromuscular blocker was considered a day of neuromuscular blockade.
Medication doses from the medical record were recorded onto a standardized data collection form and entered into a central database. Data collectors were blinded to the patient's treatment group by accessing only the medication records within the medical chart; progress notes, nursing flow charts, and respiratory flow charts were not accessed. A random subset of 20% of patient charts was doublechecked for accuracy, and no discrepancies were found. Demographic data, including gender, age, Acute Physiology and Chronic Health Evaluation III, primary ALI risk factor, PaCO 2 , length of mechanical ventilation, and delivered tidal volumes, were obtained from the ARDS Network database.
Statistical Analysis. All comparisons are between patients receiving the lower tidal volume strategy and patients receiving the higher tidal volume strategy. Values are expressed as the mean Ϯ SD for continuous variables or frequency and percentage for categorical variables. Differences in baseline characteristics between groups were assessed with an unpaired Student's t-test or Wilcoxon's rank-sum test for continuous variables and a chi-square test for categorical variables. An unpaired Student's t-test was used to compare the mean percentage of days patients received sedation. Fisher's exact test or a chi-square test was used to compare the proportion of patients who received medication on a given day. Wilcoxon's rank-sum test was used to assess for significant differences between doses of individual drugs.
The difference in median dose for specific drugs was calculated by subtracting the median of the higher tidal volume group from the median of the lower tidal volume group; negative differences indicate that the median dose was higher in the higher tidal volume group. Confidence intervals around the difference in median daily drug dose were obtained by standard bootstrap methods (25) . To account for some patients receiving both narcotics and analgesics together (thus possibly obscuring a potential effect of treatment group on the individual drug comparisons), we performed O'Brien's generalized rank score test (26) . This test ranks sedation and analgesic administration per patient for each day, takes the mean of the two ranks for each individual, and then tests the mean rank for each group.
A post hoc power calculation was performed using the observed group numbers and standard deviations and correcting for the nonparametric distribution of drug doses. The study had Ͼ80% power to detect a 4 mg/hr increase in morphine equivalents and lorazepam equivalents per day in the group receiving lower tidal volumes.
Data analysis was performed using Stata 8.2 (StataCorp, College Station, TX), except for the power calculation, which was performed using PASS 2002 (NCSS, Kaysville, UT). All tests were two-tailed, and p Յ .05 was considered significant.
RESULTS
Seventy-three patients were enrolled in the ARDS Network tidal volume trial at our institution. Twelve patients could not be included due to incomplete medical records. These patients were evenly distributed among the study groups (seven in the higher tidal volume arm and five in the lower tidal volume arm) and came from throughout the study period. Of the 61 patients available for analysis, 33 patients were randomized to the lower tidal volume arm and 28 patients were randomized to the higher tidal volume arm. As shown in Table 1 , groups were similar with regard to age, race, and Acute Physiology and Chronic Health Evaluation III score. The lower tidal volume group had a higher proportion of women as well as a higher proportion of patients with sepsis as the primary risk factor for ALI, although these differences were not statistically significant. Actual tidal volumes closely approximated the random assignments for each group on days 1, 2, 3, and 7 of the study period. There were no statistically significant differences in days of mechanical ventilation between groups.
Fifty-eight patients (95%) received a sedative agent during the study period, including benzodiazepines and propofol. Forty-five patients (74%) received a benzodiazepine alone, two patients (3%) received propofol alone, and 11 patients (18%) received both a benzodiazepine and propofol at different times during the study period. Fifty-seven patients (94%) received opioid analgesia during the study period. Twelve patients (20%) received at least one dose of haloperidol, and 17 patients (28%) received at least one dose of a neuromuscular blocker.
When we compared the two treatment groups, there were no statistically significant differences in the mean percentage of study days that patients received sedation, opioid analgesia, and neuromuscular blockade. Patients received sedatives (including benzodiazepines and propofol) an average of 81% of study days in the lower tidal volume group and 92% of study days in the higher tidal volume group (difference in percentage ϭ Ϫ11%; 95% confidence interval, Ϫ24% to 3%; p ϭ .13). Patients received opioid analgesia an average of 85% of study days in the lower tidal volume group compared with 83% of study days in the higher tidal volume group (difference in percentage ϭ 2%; 95% confidence interval, Ϫ14% to 18%; p ϭ .85). Patients received neuromuscular blockade an average of 5% of study days in the lower tidal volume group compared with 13% of study days in the higher tidal volume group (difference in percentage ϭ Ϫ8%; 95% confidence interval, Ϫ20% to 3%; p ϭ .16). Table 2 shows the number and percentage of patients receiving specific drugs on days 1, 2, 3, and 7 of enrollment. No statistically significant differences be-tween groups were observed for benzodiazepines, propofol, haloperidol, or opioids. Figures 1 and 2 demonstrate box plots indicating the specific drug doses of benzodiazepines (in lorazepam equivalents) and opioids (in morphine equivalents) on those days. There was wide variability in the doses of individual drugs that patients received, but there was no detectable difference between study groups. The actual difference in median doses is given in Table 3 ; using bootstrapped confidence intervals, the median dose difference was not significantly different from zero on any day.
When we used the O'Brien rank score analysis, there was no statistically significant difference in the combined sedative and analgesic drug use on days 1, 3, and 7 of enrollment (p ϭ .90, .08, and .40, respectively).
DISCUSSION
In 61 patients enrolled in the ARDS Network tidal volume trial at our institution, patients randomized to the low tidal volume arm did not receive increased dose or duration of sedating medications. This result was consistent when sedative use was examined as the proportion of study days requiring sedatives; as the proportion of patients receiving sedatives on days 1, 2, 3, and 7 of mechanical ventilation; and as the total dose received on those days. Moreover, patients receiving a low tidal volume strategy did not receive increased days of neuromuscular blockade compared with the traditional tidal volume strategy.
These findings are important due to recent studies suggesting that the outcome of patients with critical illness may be improved by reducing the level of sedative doses. Ely and colleagues (17) showed that higher sedative doses were associated with ICU delirium, which is an independent risk factor for mortality in the critically ill. In an observational study, Kollef et al. (14) found that continuous sedation was independently associated with prolonged duration of mechanical ventilation in a diverse patient population. More recently, Kress and colleagues (15, 27, 28) found that patients randomized to daily trials of interrupted sedation had a shorter duration of mechanical ventilation, shorter ICU stays, and fewer investigations into altered mental status without worsening post-ICU psychological morbidity.
Increased sedation requirements are frequently cited as a reason not to implement the ARDS Network protocol. A recent controversial review of the ARDS Network study considered "higher doses of sedatives and narcotics necessary to maintain patient comfort [and] the addi- NA, not applicable. a A negative difference indicates that a higher proportion of patients received the drug in the 12 mL/kg group. Differences may not be exact due to rounding. Data presented as frequency (percentage). Percentages reflect only those patients still receiving mechanical ventilation (i.e., not extubated or dead). tion of neuromuscular blockade" as possible explanations for the authors' conclusions that the ARDS Network low tidal volume strategy may actually increase mortality (11) . The authors of an instructional article on implementing the ARDS Network protocol wrote that "high levels of sedation are often necessary to eliminate severe respiratory distress and patient-ventilator discoordination" in lungprotective ventilation (4) . A recent review of evidence-based medicine in the ICU questioned whether low tidal volume ventilation "requires increased sedation and maybe even a need for a paralytic agent," thus potentially limiting its applicability (6) . Additionally, a recent qualitative study found that nurses and respiratory therapists frequently cite patient discomfort and increased sedation needs as important barriers to implementing the ARDS Network lung-protective ventilation protocol (5).
The results of this study suggest that a low tidal volume ventilation strategy does not increase sedative use among patients with ALI. In fact, the presumption that lung-protective ventilation requires increased sedation is largely anecdotal and has not previously been explored empirically. It is possible that the rapid shallow breathing pattern created by lower tidal volumes and higher respiratory rates simply appears uncomfortable to caregivers but is not a source of discomfort for the patient. Furthermore, other factors, such as the presence of an endotracheal tube (29) , airway suctioning (30), ambient noise (31), sleep disruption (32), or procedures (33) may contribute to patient discomfort to such a degree that the mode of mechanical ventilation has a minor effect.
This investigation also extends the findings of a recent study examining sedation use within the first 48 hrs in ARDS Network patients (33a) . That study showed no difference in the proportion of patients receiving continuous sedation or the total daily dose of some sedative agents in the first 2 days. This further confirms that patients in the two treatment groups received similar care with regard to sedative administration.
Our study has several limitations. For one, these findings reflect sedation practice at a single institution and therefore may not generalize to other ICUs. Our results, however, are compatible with data from the entire ARDS Network study demonstrating that the number of days of sedation and neuromuscular blockade was similar in both study arms (3) . Also, since a sedation protocol with formal sedation scoring was not in place at the time of the ARDS Network trial, it is possible that both groups were oversedated, obscuring any differences due to the ventilation strategy. This seems unlikely, since with the exception of outliers in both study groups, the doses of sedative medication for patients in this study were similar to the doses received by mechanically ventilated patients in other recent studies (15, 34 -36) .
Our study is also limited by its power to detect statistically significant differences between study groups. Our study, however, was larger and had greater statistical power than other studies that found statistically significant differences in sedation use attributed to mode of mechanical ventilation in patients with ALI (20, 21) . Additionally, the differences in both the mean proportion of sedative days and sedative doses on days 1, 2, 3, and 7 of mechanical ventilation were generally in the direction of increased sedative use in the higher tidal volume arm. This makes it less likely that a true increase in sedation requirements for patients in the low tidal volume group was missed due to low power. Since ARDS Network patients in the higher volume arm generally had worse outcomes, including fewer organ failure free days (presumably due to less ventilator-induced organ failure), this also supports the hypothesis that severity of illness, rather than ventilator mode, influenced sedative drug use in the study. Kidney and hepatic failure in the high tidal volume arm patients might have led clinicians to use lower doses of all medications including those evaluated in this study. This potential bias actually strengthens our conclusion that a low tidal volume strategy does not require increased sedatives and analgesics because our study showed no statistically significant differences in drug dosing, and where there were differences they favored higher doses in the higher tidal volume group.
There is also the possibility that differences in length of mechanical ventilation and mortality between the groups confounded our results. This is unlikely, as we analyzed the proportion of ventilator days patients received sedation and doses on specific individual days, rather than absolute number of days or dose over the total ICU stay. Consequently, differences in total ventilator days should not have affected the analysis. Also of note is the number of subjects who were excluded due to incomplete medical records (12 patients total, comprising 16% of the entire group). Importantly, the data for these patients were unavailable purely due to missing records rather than systematic differences between themselves and the rest of the study patients. Moreover, these patients were evenly distributed throughout the study period and among both study groups, making bias unlikely.
Current evidence suggests that only a minority of patients with ALI actually receive low tidal volume ventilation (37) (38) (39) . Reasons for this are numerous, including poor provider recognition of the syndrome and physician preference as well as concerns over patient comfort and sedation requirements (5) . This study, however, does not indicate that low tidal volume ventilation increases sedation and analgesia use in the ICU. At this time, increased use of sedation, opioid analgesia, and neuromuscular blockade should not be considered an important barrier to implementing a lung-protective ventilation strategy in patients with ALI. Future studies are needed to identify optimal sedation practice in ALI, particularly with regard to duration of mechanical ventilation, recall of traumatic events, and longterm outcomes of critical illness (40 -42) . 
